Viral Hepatitis B: Clinical Trials

8 trials for Viral Hepatitis B, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown, 1 completed, 1 no longer available, 1 recruiting. 3 Not applicable, 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable3Unknown 2, Completed 1
Phase 11Terminated 1
Phase 41Unknown 1

Follow Viral Hepatitis B: new trials by email Literature Review of Viral Hepatitis B trials Research Report on Viral Hepatitis B

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DEcentralize Testing, Education, and Linkage to Care by Using Electronic Best Practice Advisory for Hepatitis B (DETECT-B)
An enhanced model of hepatitis B testing and linkage to care - Viral Hepatitis B
Not applicableUnknownVietnam Viral Hepatitis Alliance302024-05-012024-05-08
"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
Blood sample during surgery, Taking an additional biopsy, Blood sample during diagnostic test - Chronic Liver Disease and Cirrhosis, Liver Cancer
RecruitingInstitut National de la Santé Et de la Recherche Médicale, France8002021-01-142026-10-22
Sexual and Reproductive Health (Including PrEP and HBV) for Female Sex Workers in Côte d'Ivoire
Comprehensive package of sexual and reproductive health services - HIV Infections, Viral Hepatitis B
Not applicableUnknownANRS, Emerging Infectious Diseases5002019-11-262022-06-07
Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection
Engerix-B - Viral Hepatitis B, Immunization; Infection
Phase 4UnknownNational Taiwan University Hospital5752017-09-062020-05-22
Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy Volunteers
AL-3778, Entecavir, Tenofovir disoproxil fumarate - Hepatitis B, Chronic Hepatitis B
Phase 1TerminatedAlios Biopharma Inc.542017-01-312017-10-16
Therapeutic Option for Hepatitis B and C: a French Cohort
Viral Hepatitis B, Viral Hepatitis C
UnknownANRS, Emerging Infectious Diseases209022012-08-062023-01-31
Blood-borne Infection Screening in an Afghan Antenatal Population
Concentrated postpartum counseling - Viral Hepatitis B, Contraception
Not applicableCompletedColumbia University12912008-06-012017-05-17
Replicor Compassionate Access Program
REP 2139-Mg, Tenofovir Disoproxil Fumarate, Pegylated interferon alpha2a - Viral Hepatitis B, Viral Hepatitis D
No longer availableReplicor Inc.2025-02-17

Narrower conditions

Hepatitis B (8)  ·  Fibrosis (2)  ·  HIV Infections (2)  ·  Hepatitis C (2)  ·  Hepatitis D (2)  ·  Breast Feeding (1)  ·  Carcinoma, Hepatocellular (1)  ·  Esophageal and Gastric Varices (1)  ·  Hepatitis B, Chronic (1)  ·  Infections (1)  ·  Liver Cirrhosis (1)  ·  Liver Diseases (1)  ·  Liver Neoplasms (1)  ·  Non-alcoholic Fatty Liver Disease (1)  ·  Sexually Transmitted Diseases (1)

Broader conditions

Blood-Borne Infections (8)  ·  Communicable Diseases (8)  ·  DNA Virus Infections (8)  ·  Digestive System Diseases (8)  ·  Hepadnaviridae Infections (8)  ·  Hepatitis (8)  ·  Hepatitis, Viral, Human (8)  ·  Virus Diseases (8)  ·  Infections (7)  ·  Liver Diseases (7)  ·  RNA Virus Infections (5)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Digestive System Neoplasms (2)  ·  Disease Attributes (2)

Interventions

Tenofovir (2)  ·  Engerix-B (1)  ·  NVR 3-778 (1)  ·  Reproductive Health Services (1)  ·  entecavir (1)  ·  peginterferon alfa-2a (1)

Sponsors

ANRS, Emerging Infectious Diseases (2)  ·  Alios Biopharma Inc. (1)  ·  Columbia University (1)  ·  Institut National de la Santé Et de la Recherche Médicale, France (1)  ·  National Taiwan University Hospital (1)  ·  Replicor Inc. (1)  ·  Vietnam Viral Hepatitis Alliance (1)

Countries

France (3)  ·  Afghanistan (1)  ·  Austria (1)  ·  Côte d’Ivoire (1)  ·  Israel (1)  ·  Italy (1)  ·  New Zealand (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)

Top investigators

Catherine Todd, MD (1)  ·  Chien-Ching Hung, MD, PhD (1)  ·  Joseph Larmarange, PhD (1)  ·  Thanh Kim, MD (1)  ·  William D Kennedy, MD (1)

Results publications

PMID 27622858, PMID 30765123, PMID 30940090, PMID 32798585, PMID 33993651, PMID 34142073, PMID 34863122, PMID 35086481, PMID 35690798, PMID 35927368, PMID 37587323, PMID 38133601, PMID 39132068, PMID 39252600, PMID 39897611, PMID 40598581, PMID 41205755

NIH funding

K01TW007408 (1)